Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. Phase 1 Clinical trials in the US are underway.
| Website | http://www.endevicabio.com |
| Employees | 17 (17 on RocketReach) |
| Founded | 2009 |
| Address | 1601 S Providence Rd, Columbia, Missouri 65211, US |
| Industry | Biotechnology Research |
| Keywords | Peptide Therapeutics, Therapeutic Peptides, Chronic Disease Treatment, Phase 1 Clinical Trials, Clinical Stage, Drug Development, Novel Therapeutics, Medical Research, Biotechnology, Pharmaceutical Research, Clinical Development, Cancer Research, Biopharmaceutical, Oncology, Health |
| Competitors | BioMarin Pharmaceutical Inc., CRISPR Therapeutics, CureVac, Sangamo Therapeutics, Inc., Audentes Therapeutics, Bioneer, Plexxikon Inc., NantKwest, ANAVEON AG, Axovant Sciences Ltd +46 more (view full list) |
Looking for a particular Endevica Bio employee's phone or email?
Tatiana Wood is the Director of Finance of Endevica Bio.
17 people are employed at Endevica Bio.
Endevica Bio is based in Columbia, Missouri.